Replies to post #7451 on $Amazing $Biotech & $olid $Microcap $tocks

[kei]

hi Eagle :) very sorry for the late reply!
we are just fine - please follow us on twitter ... btw, i bought $KRUS yesterday at $15.75 and i added twice yesterday and i added more at open today! ~ new IPO yesterday ~ this one might go $35, even $50 ? ... not sure but i like tiny offering ~ i've been tweeting since it opened IPO... my best price is at low $15 ~ regret that i didn't go all in at open!

[BottomBounce]

$BNGO Professor at Baylor College of Medicine, who used data from the Saphyr system to analyze repeat-mediated inversions, which are complex genomic structures that are hard or impossible to resolve with other molecular methods but can predispose to genetic disease; Tina Graves-Lindsay from the McDonnell Genome Institute at Washington University, who corrected structural errors in the official human reference genomes with data generated with Saphyr; and Amir Trabelsi, CEO of Genoox, who announced the new release of a software pipeline that now automatically validates, annotates and classifies Bionano translocation calls from whole genome sequence data. http://www.globenewswire.com/news-release/2019/10/24/1934941/0/en/Takeaways-from-ASHG-2019-in-Houston-Users-of-Bionano-s-Saphyr-System-Presented-Validation-Results-for-FSHD-Repeat-Expansion-Disorders-and-Digital-Cytogenetics-Among-a-Growing-List-.html

[BottomBounce]

$INO Inovio plans to rapidly develop INO-4800 against the new coronavirus and has already started preclinical testing and preparations for clinical product manufacturing. The goal of this collaboration is to leverage Advaccine's expertise to run a Phase 1 trial in China in parallel with Inovio's clinical development efforts in the U.S. Inovio and Advaccine will also work together to attract additional grant funding and further collaborations with larger vaccine companies in China to increase the speed of future testing of INO-4800.